PNC-27 – 10mg
$250.00
PNC-27
PNC-27 is a synthetic peptide that researchers have investigated its potential to selectively target cells. Therefore, PNC-27 is particularly notable for its ability to penetrate cell membranes and induce apoptosis, which makes it a subject of growing interest in research.
Potential Research Applications
PNC-27 is currently being explored in research settings for its role in:
- Tumor Suppression & Apoptosis: Researched for its role in stimulating apoptosis by interacting with the cell membranes of cells and triggering cell death mechanisms.
- Targeted Drug Delivery: Explored for its potential to serve as a delivery vehicle, improving the efficacy and specificity of therapeutic agents.
- Oncolytic Applications: Investigated for its potential in oncolytic treatments, where the peptide may aid in breaking down bad cells while sparing healthy ones.
✔ High-Quality Research Peptide – Produced under stringent quality control standards.
✔ Lab-Tested for Purity – Ensures consistency for scientific studies.
✔ Research Use Only – Not for human consumption or medical applications.
✔ Peptides – Will arrive in a lyophilized (powder) form for maximum stability.
The peptides are available for research and laboratory purposes only. Please review and ahere to our Terms and Conditions before ordering.
- Description
- Certificate of Analysis
PNC-27 is a synthetic peptide derived from a portion of the p53 tumor suppressor protein. P53 regulates the cell cycle, DNA repair, and apoptosis. Researchers designed PNC-27 to selectively target and kill abnormal cells while leaving healthy ones unaffected.
PNC-27 binds to HDM-2, a protein that inhibits p53. P53 prevents tumor growth by inducing cell cycle arrest or apoptosis in damaged cells. In many cases, HDM-2 blocks p53, allowing abnormal cells to proliferate uncontrollably. By interacting with HDM-2, PNC-27 restores p53 activity, leading to cell death and inhibiting tumor growth.
PNC-27 has shown potential in targeting various abnormal cell types, such as those in breast, prostate, and pancreatic tissues. Researchers found that PNC-27 selectively recognizes and binds to abnormal cell membranes. This selectivity helps deliver the peptide to targeted tissue while minimizing damage to healthy cells. Therefore, this factor makes PNC-27 an area of interest in research.
Moreover, PNC-27’s ability to target abnormal cells directly has sparked interest in its potential as a therapeutic agent. Preclinical studies suggest that PNC-27 can induce significant tumor regression in multiple models. It may also complement existing treatments, offering new possibilities. However, further studies and clinical trials are necessary to determine its safety and efficacy in humans.
Currently, PNC-27 is primarily used in labs to study its mechanisms of action and potential. Researchers focus on its ability to induce apoptosis, its interactions with HDM-2, and its possible synergy with other treatments. It is not currently approved for human use, and its clinical development is still in early stages.
No Certificate of Analysis images available for this product.
